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a b s t r a c t
Precise control of lineage-speciﬁc gene expression in the neural stem/progenitor cells is crucial for
generation of the diversity of neuronal and glial cell types in the central nervous system (CNS). The
mechanism underlying such gene regulation, however, is not fully elucidated. Here, we report that a
377 bp evolutionarily conserved DNA fragment (CR5), located approximately 32 kbp upstream of Olig2
transcription start site, acts as a cis-regulator for gene expression in the development of the neonatal
forebrain. CR5 is active in a time-speciﬁc and brain region-restricted manner. CR5 activity is not detected
in the embryonic stage, but it is exclusively in a subset of Sox5þ cells in the neonatal ventral forebrain.
Furthermore, we show that Sox5 binding motif in CR5 is important for this cell-speciﬁc gene regulatory
activity; mutation of Sox5 binding motif in CR5 alters reporter gene expression with different cellular
composition. Together, our study provides new insights into the regulation of cell-speciﬁc gene
expression during CNS development.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
During the development of the central nervous system (CNS),
the cellular diversity emerges largely from controlled spatiotem-
poral segregation of cell type-speciﬁc molecular regulators (Butt
et al., 2005; Fode et al., 2000; Hoshino, 2012; Lo et al., 2002;
Molyneaux et al., 2007; Parras et al., 2002). A large number of
different neurons and glial cells are derived from a population of
self-renewing stem and progenitor cells. Well-orchestrated line-
age-speciﬁc gene expression in the neural stem/progenitor cells is
crucial for the generation of these neuronal and glial cell types
(Dessaud et al., 2008; Panman et al., 2011). However, it is not quite
clear how the differentiation of neural progenitors and the
acquisition of their cell-fate is processed and programmed.
Different types of neurons and glial cells in the brain originate
from separate progenitor pools in distinct areas (Marin and
Rubenstein, 2001). Many transcription factors are important reg-
ulators during this neural differentiation process. One group of
such transcription factors are the basic helix-loop-helix (bHLH)
transcription factors which involved in the determination of
neural cell fates (Akagi et al., 2004; Bertrand et al., 2002).
Oligodendrocyte transcription factor (Olig) is a family of bHLH
proteins that has received great attention for its essential role in
neural cell speciﬁcation and differentiation (Lu et al., 2001; Lu
et al., 2002; Yu et al., 2013; Zhou and Anderson, 2002). The
expression of the Olig gene family is predominantly restricted to
the CNS (Lu et al., 2000; Zhou et al., 2000). Olig2, a member of Olig
gene family, is required for the formation of oligodendrocyte and
motoneuron progenitors; Olig2 null mouse embryos do not form
oligodendrocytes and die at birth (Lu et al., 2002; Zhou and
Anderson, 2002). Although the role of Olig2 in the development
of the CNS has been well established, little is known about the
molecular mechanism underlies spatiotemporal Olig2 expression
during development. Other factors involved in neurogenesis dur-
ing the CNS development include the Sox family transcription
factors (Azim et al., 2009; Wegner and Stolt, 2005). Sox5 is a
member of the Sox D group widely expressed in the developing
forebrain and involved in the formation of the cephalic neural
crest, in the control of cell cycle progression in neural progenitors,
and of the sequential generation of distinct corticofugal neuron
subtypes (Lai et al., 2008; Martinez-Morales et al., 2010; Perez-
Alcala et al., 2004).
Neurogenesis is a developmental process highly conserved
across a wide range of species (Finlay and Darlington, 1995;
Gomez-Skarmeta et al., 2006). The evolutionarily conserved non-
coding component of the genome is known to play an essential
role in regulating this developmental process and has been
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
http://dx.doi.org/10.1016/j.ydbio.2014.06.010
0012-1606/& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
n Corresponding author. Fax:þ1 732 445 3753.
E-mail address: lcai@rutgers.edu (L. Cai).
1 Current address: Departments of Medicine (Cardiovascular) and of Radiology,
Stanford University, Stanford, CA 94305, United States.
Developmental Biology 393 (2014) 183–193
receiving increased attention because of its predicted function in
regulation of transcription, DNA replication, chromosome pairing,
and chromosome condensation (Blackwood and Kadonaga, 1998;
Jeziorska et al., 2009; Long and Miano, 2007). DNA sequences
involved in gene regulation through the binding of transcriptional
factors, termed as cis-regulatory elements, enhance or suppress
gene expression in a spatiotemporal manner. The regulatory
function is independent of orientation or position relative to the
transcription sites (Blackwood and Kadonaga, 1998; Jeziorska et
al., 2009). Several non-coding DNA fragments have been demon-
strated to inﬂuence the expression of the Olig1 and/or Olig2 genes
(Friedli et al., 2010; Sun et al., 2006). However, the trans-acting
factors that activate these DNA fragments still need to be
identiﬁed.
In search for distant cis-elements of Olig2 gene, we identiﬁed a
highly evolutionarily conserved non-coding DNA element (CR5)
upstream of the Olig2 gene transcription start site. CR5 plays
essential roles in regulating gene expression in a subpopulation of
Sox5þ cells that exclusively located in the ventral forebrain during
the neonatal CNS development. We present evidence that the
binding motif for Sox5 is important for the regulatory activity of
this cis-element. Our ﬁndings may provide new insights into
molecular mechanism underlying cell-speciﬁc gene expression.
Material and methods
Sequence alignment analysis
The sequence and annotation of the mouse Olig2 gene along
with its homologs from the human, rat, cow and zebraﬁsh
genomes were retrieved using NCSRS (Doh et al., 2007). The
sequences were analyzed by VISTA (Frazer et al., 2004) to identify
highly conserved regions (CR). The percent identity and the length
of the conserved sequence were used to calculate a score for each
conserved region (score¼percent identityþ(length/60)). A limit of
2 kb in sequence length was implemented in order to isolate
individual cis-elements for this study. Based on this scoring
system, the percent identity was more heavily weighted to ensure
that shorter and highly conserved sequences are not ranked below
longer sequences with lower levels of conservation (Fig. S1).
Reporter plasmid constructions
Computationally-predicted conserved regions were ampliﬁed
using the Taq PCR Kit (New England Biolabs, MA) following the
routine Taq PCR reaction protocol. Primers used were summarized in
Table 1. Mouse genomic DNA (Swiss Webster strain) was extracted
from an adult mouse tail and used as the PCR template for all
primers. A random extension sequence (CGATATAT) and the SpeI
recognition sequence (ACTAGT) was added to the 5' end of the
forward primer, plus a random extension sequence and FseI recogni-
tion sequence (GGCCGGCC) was added to the 5' end of the reverse
primer. Then, the sticky end inserts were digested, gel puriﬁed, and
ligated into the βGP-GFP backbone which was linearized with FseI
and SpeI to generate experimental constructs (Fig. S1).
Animals and ethics statement
For in vivo and in utero electroporation experiments, Swiss
Webster mice were purchased from Charles River Laboratories
(Wilmington, MA) and maintained on a 12 h/12 h (7:00 a.m. to
7:00 p.m.) light/dark schedule from the time of arrival until the
time of the experiment. Pregnancies were timed from the day
at which a vaginal plug was detected, which was designated as
embryonic day 0 (E0). By this convention, birth would normally
occur on E19. This strain was also used as recipient to implant
0.5 dpc (days post coitum) embryos for transgenic animal studies.
Mice were randomly assigned to distinct experimental groups. All
studies were conducted in accordance with the NIH guidelines for
the care and use of animals with approved animal protocol from
the Institutional Animal Care and Use Committees at the Rutgers
University.
In vivo electroporation
Individual experimental plasmid DNA constructs (2–3 mg/ml)
were mixed with the control plasmid (2–3 mg/ml) to make the
working DNA mixture. 1 ml DNA mixture was delivered into the
mouse brain at postnatal day 0 (P0) targeting the SVZ progenitors
(Fig. S1) with a Hamilton syringe. Five square pulses (80 V) of
50 ms duration with 950 ms intervals were then applied using a
pulse generator ECM 830 (BTX Harvard Apparatus).
In utero electroporation
Timed pregnant Swiss Webster female mice (Charles River
Labs) were anesthetized by intraperitoneal delivery of 0.7–0.9 ml
of 2.5% avertin. The abdomen was opened to expose the
uterine horns. The DNA solution (1 μg/μl experimental plasmid
DNAþ0.025% fast green) was injected into the lateral ventricle of
embryonic brains at E15.5 using a pulled glass micropipette. After
injection, the head of each embryo was placed between tweezer-
type electrodes (BTX Harvard Apparatus) and ﬁve square electric
pulses (37 V, 50 ms) were delivered with 950 ms intervals using a
pulse generator ECM 830 (BTX Harvard Apparatus). The wall and
skin of the abdominal cavity were then sutured and closed.
Generation of transgenic mice
Digested DNA (CR5-GFP) was gel puriﬁed using Seakem GTG
agarose gel. Puriﬁed DNA (3–5 pg) was introduced by microinjec-
tion into 0.5 dpc (days post coitum) fertilized F1 (C57Bl/6J x CBA,
Jackson Labs) mouse embryos and transferred to pseudopregnant
recipient females. Reimplanted embryos were allowed to develop
in utero to a time point that recipient female were sacriﬁced or
allowed to give birth. Skin or tail DNA was prepared following
standard protocol for genotyping. The transmission of the trans-
gene in following generations was veriﬁed by Southern blotting
and/or PCR genotyping (forward primer: GCA ACG TGC TGG TTA
TTG TGC TGT; reverse primer: GTG GTA TTT GTG AGC CAG
GGC ATT).
Tissue harvesting, processing and immunohistochemistry
Tissues from mouse brain were harvested at various embryonic
and postnatal stages, ﬁxed in 4% paraformaldehyde overnight, and
washed in PBS 3 times for 5 min at 4 1C. Tissues were cryopro-
tected in 30% sucrose overnight until they became submerged in
solution at 4 1C; they were embedded in OCT, sectioned at
10–15 μm thickness using a cryostat (Thermo 0620E), mounted
on Superfrost slides (Fisher Scientiﬁc), and air-dried for 30 min.
Immunostaining was performed using a Shandon Slide Rack
(Thermo Scientiﬁc, MA) as previously described (Doh et al.,
2010). Sections were incubated in blocking solution (0.05% Triton
X-100, 10% goat serum, 3% BSA in PBS) for 30 min at room
temperature followed by an overnight incubation with primary
antibodies. GFP signal was retrieved by staining with anti-GFP
(1:1000 dilutions, Invitrogen; 1:500 dilution, Abcam). Other pri-
mary antibodies included anti-NeuN (1:1000 dilution, Millipore),
Sox5 (1:200 dilution, Santa Cruz), NG2 (1:200 dilution, Millipore),
Tbr1 (1:200 dilution, Santa Cruz), Tbr2 (1:200 dilution, abcam),
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Gsx1 (1:200 dilution, Santa Cruz), PDGFRα (1:1000 dilution,
abcam), GFAP (1:1000 dilution, Sigma), BLBP (1:1000 dilution,
Chemicon), Pax6(1:200 dilution, Millipore), Mash1(1:100 dilution,
BD Biosciences), S100β (1:1000 dilution, Sigma), PH3 (1:100
dilution, abcam), and Ki67 (1:100 dilution, BD Pharmingen).
Staining with anti-Olig2 antibody (a gift from Dr. Charles Stiles
at Harvard University) required pre-heating of slides with 1 mM
Tris-EDTA buffer (PH 8.5) at 96 1C for 12 min to retrieve the
antigen. Slides were then washed with PBS. Subsequently, tissue
sections were incubated with appropriate secondary antibodies
conjugated to different ﬂuorophores (donkey anti-RbIgG Alexa
488 or donkey anti-GtIgG Alexa 488, 1:300, Jackson ImmunoR-
esearch Labs) (donkey anti-mIgG Alexa 647 or donkey anti-RbIgG
Alexa647, 1:150, Jackson ImmunoResearch Labs). Secondary anti-
bodies were prepared in blocking buffer and applied at room
temperature for 1 h, followed by three 10 min washes with PBS
and a 5 min rinse in distilled water to remove salt crystals. After
air-drying for 5 min, slides were mounted with 40 μl of mounting
media with Dapi (Vector Laboratories).
Cell counting and statistical analysis
For counting double-labeled cells, confocal images were cap-
tured using a digital Zeiss AxioCam MR camera using a Zeiss Axio
Imager Z1 with ApoTome application (Optical sectioning using
structured illumination), and analyzed to detect GFPþ cells and
cells stained with a speciﬁc marker. The number of GFPþ cells and
GFPþ cells co-stained with a cell type-speciﬁc marker was counted
manually in 4–5 sections from at least 3 animals per time point. In
addition, DAPI staining was used to ensure that GFPþ cells were co-
labeled with a cell marker (Fig. S2). The percentage of co-labeled
cells over total number of GFPþ cells was determined. Results were
presented as mean7SD. Statistical signiﬁcance was determined
using student's t-test at the level of po0.01.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed to identify sub-regions of CR5 with
potential binding activity with transcription factors. MatInspector,
Table 1
A list of computationally predicted conserved regions.
cis-element Chr16 start position Chr16 end position Conserved region (bp) Primer sequence
CR1 91062084 91062946 863 forward ATGCAAGCCTGTGTCTCTGACGAT
reverse TTGAGCAGTCTGGGTGAGGACAAA
CR2 91064822 91065087 266 forward AAGCCGCTGTCCACTATCCTTCAT
reverse ACAGCTGTGGTCCAGGTGAATCTT
CR3 91080246 91081050 805 forward ATGAGAACACGTCATTGGCTTCGG
reverse TGACTTTGGGAAGAGGGAGAGAGT
CR4 91081310 91081883 574 forward TGTGTAGGCCACAAACAGGAGACT
reverse GCGAGCCGCTTAAGCTTCATCAAT
CR5 91082197 91082573 377 forward ATTTGCGCTCTAAGGATGGCACAC
reverse ACCTTGACTCCCAAGTAGCCCTAT
CR6 91095187 91095771 585 forward TGCGGATCACGAGTAGCTTCCATT
reverse TGCCGCACCATTTGAACTCTGAAG
CR7 91097808 91098766 959 forward CCTTGCTTGCCAGGAGCATGAAAT
reverse TGTTGACAATGTGGTGTTTGCGGG
CR8 91100392 91100662 271 forward GTGCACCAATGCTCACTGAAATGC
reverse TGGGTATGTTGAGTTGGAGGCACA
CR9 91111442 91111756 315 forward TCGCTGCCTGAATGCTAGTAGGAA
reverse TGGGAATGGAGAGTTCACTTGCCT
CR10 91112578 91112794 217 forward TCCTCACATGCCCAAGCTCCTAAT
reverse GCGATTGCTCCTCATTTCGTGCTA
CR11 91121114 91121281 168 forward ACTGGCTTAGCTCCAACAGGGAAA
reverse TGGTCTCTCTCCGCAAGCATGAAT
CR12 91135088 91135543 456 forward TGACTCTTGTTCCCAGCCCTTTCA
reverse TTGCCACTCTGGACACTTACAGCA
Table 2
A list of EMSA probes for CR5.
EMSA probes Forward sequence Potential binding transcription factors
Probe #1 GCCCTGGGACCCCCACCAATAAATTATGGGTGGACATTAGGGGAGAGCCCAGGA WT1
PHOX2a
ISL2
PAX6
PIT1
EN1
PHOX2
Probe #2 CGTGAGGGCAGCCTGCATTGTAAATTACAATTAAAACAGAAACAGACAGTTCCT SOX5
HOXB6
MEOX1
NKX25
EN1
HOXB8
Probe #3 ATGACCAAGATGGGGACATTGTGTTTACCTACTTGAG
Probe #4 ACCTACTTGAGCAGAGGAGAAGGTGACCGTGAGGGCAGCCT
Probe #5 TCAGATAATCGCCTCCCTCCCGGCTGTCAGGGGTGCAGCCACTGCCAAT
Probe #6 CAGCCACTGCCAATTCACAGCGCCCTCCGAGAAAGTACCCTTGTCTGTGAT
Probe #7 GATGGCACACTCCATTTGATAATGGCTCTCATCTGCCTCAGATAATCGCC
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an online search tool from Genomatix (Germany) that provides
potential trans-acting factor binding sites in nucleotide sequences
(Cartharius et al., 2005; Quandt et al., 1995; Werner, 2000), was
used to identify known sequence-speciﬁc binding sites for protein
factors. Double-stranded DNA probes (40–80 bp in sequence
length) were designed to span the entire conserved region
(Table 2). Probes were synthesized (IDT, Piscataway, NJ) as single
stranded oligonucleotides, biotinylated using the Biotin 3´ End
DNA Labeling Kit (Thermo Fisher Scientiﬁc) and annealed at room
temperature one hour immediately prior to binding assay. Unla-
beled single stranded probes were annealed and used as double-
stranded competition probes. A ratio of 40:1 was used for
competition probe to labeled probes. Nuclear extracts were pre-
pared from the brain tissues (the VZ and SVZ of the cerebral
cortex, the striatum and the ventral forebrain) of the Swiss
Webster mice at various stages. The EMSA binding reaction and
competition reaction were performed according to the LightShift
Chemiluminescent EMSA Kit (Thermo Fisher Scientiﬁc) protocol.
The reaction mixture was loaded onto a 10% non-denaturing
polyacrylamide gel containing 0.5 TBE (40 mM Tris, 40 mM
borate, 1 mM EDTA). Mini (880.1 cm) gels were run at 100 V
for 220 min at 4 1C and dried under vacuum.
Chromatin immunoprecipitation assay (ChIP)
ChIP assays were performed to determine which transcription
factors bind to the veriﬁed regulatory regions of CR5 in embryonic
mouse tissue using a commercially available kit (MAGnify™
Chromatin Immunoprecipitation System, Invitrogen). The brain
tissues (the VZ and SVZ of the cerebral cortex, the striatum and the
ventral forebrain) were harvested from Swiss Webster mice at
various stages. The brain tissue was homogenized through pipet-
ting. Dissociated cells were cross-linked for 15 min at 37 1C with
1% formaldehyde. The cells were incubated in lysis buffer contain-
ing protease inhibitor for 5 min on ice. Sonication for 4~6 cycles of
30 s ‘ON’ and 30 s ‘OFF’ yielded 500–1000 bp fragments of sheared
chromatin. The remaining steps were performed following the
manufacturer's instructions. Antibodies for immunoprecipitation
included anti-Phox2a, Phox2b and Sox5 (Santa Cruz Biotechnol-
ogy). ChIP DNA from individual experiments were ampliﬁed by
PCR using the primers listed in Table 1.
Results
CR5 is active in the neural progenitor cells of neonatal forebrain
To identify cis-elements that regulate cell-speciﬁc gene expres-
sion, we performed comparative sequence analysis. Twelve con-
served regions (CR1-CR12) surrounding the Olig2 gene locus were
identiﬁed (Fig. S1A); their ability to direct tissue/cell-speciﬁc gene
expression during mouse CNS development was screened by
reporter assays using in vivo electroporation (IVE). The experi-
mental DNA construct (containing a conserved region and GFP as a
reporter) was co-injected with a transfection control (CAG-DsRed)
into the developing mouse forebrain at postnatal day 0 (P0) and
electroporated to transfect the neural progenitor cells in the
ventricular zone (VZ) and/or the subventricular zone (SVZ)
(Fig. S1B and C). Reporter GFP expression was examined in
transfected tissues at various stages during the CNS development.
Fig. 1. CR5 exhibits activity in multipotent cells at P0, but not during embryonic stages. Gene regulatory activity of CR5 was tested during both embryonic and postnatal
forebrain development. For postnatal experiments, P0 SVZ was injected and electroporated with the experimental construct CR5-GFP or the control construct CAG-GFP
individually. Brain tissues were harvested at P7 seven days after electroporation. Reporter expressionwas examined on sagittal sections. CR5-GFPþ cells were detected in the
SVZ and “cc” areas of the postnatal forebrain (A). The control CAG-GFPþ cells were found in the SVZ, cc, and Cx areas and showed morphology of various cell types (B).
Higher magniﬁcations of the boxed areas in (A and B) are shown in (A1 and B1) and cells with speciﬁc morphology were indicated by arrowheads. (C) Diagrams of a mouse
brain in sagittal plane depicting targeted cells by IVE at P0 and detection of reporter gene expression at P7. The location of A and B is shown in C indicated by a blue box. For
embryonic experiments, developing VZ were co-electroporated with the experimental construct CR5-GFP and the control construct CAG-DsRed at E15.5. Brain tissues were
harvested at E17.5 two days after electroporation. Reporter expression (GFP and DsRed) was examined on sagittal sections in embryonic forebrain at E17.5. No CR5-GFP
expression was detected (D and E), while large amount of CAG-DsRedþ cells were observed in all transfected brains (red cells in D). (F) Diagrams of a mouse brain in sagittal
plane depicting targeted cells by IUE at E15.5 and detection of reporter gene expression at E17.5. Blue boxed area in F is the location of D and E. Cx, cortex; cc, corpus
callosum; LV, lateral ventricle; VZ, ventricular zone; SVZ, subventricular zone. IUE, in utero electroporation; IVE, in vivo electroporation. Scale bar¼50 mm.
H. Hao et al. / Developmental Biology 393 (2014) 183–193186
Negative control experiments were performed with DNA con-
structs containing a minimal βGP alone without a conserved
element or with a random DNA sequence comparable in size to
ensure GFP reporter expression is solely due to activity of a CR. No
GFP expression in transfected tissues was detected at any exam-
ined stages, indicating that the minimal βGP alone or a random
sequence could not direct GFP expression. Five of the 12 CRs (CR1,
3, 4, 5 and 8; see Table 1) showed gene regulatory activity and CR5
was the strongest. Thus, its gene regulatory activities were further
characterized. CR5 (Chr. 16:91082197-91082573) is a 377 bp non-
coding DNA fragment located 32 kbp upstream of Olig2 tran-
scription start site. It is 100% conserved among various mouse
strains, including C57BL/6, CBA, and Swiss Wester.
We further examined the transfection derived GFPþ cells at P7
after in vivo electroporation at P0. GFPþ cells were detected in the
SVZ and the corpus callosum of the postnatal forebrain (Fig. 1A–C).
The experimental CR5-GFPþ cells (Fig. 1A) and the control CAG-
GFPþ cells (Fig. 1B) had dramatically different morphologies in
the P7 forebrain. For example, the control CAG-GFPþ cells contain
various morphologically different cells resemble astrocyte, oligo-
dendrocyte, and radial glia (Fig. 1B,B1); while the majority of CR5-
GFPþ cells were with a radial glia or a undifferentiated cell
morphology (Fig. 1A,A1).
Since CR5 possess gene regulatory activity in neonatal stages,
its activity during embryonic development was then examined
using in utero electroporation (IUE). The lateral ventricles at
embryonic day 15.5 (E15.5) were injected and electroporated with
the experimental construct (CR5-GFP) to transfect the neural
progenitors lining the VZ/SVZ. No CR5-GFP expression was
detected in the transfected tissues at E17.5 two days after IUE
(Fig. 1D–F), indicating that CR5 may not be active at this embryo-
nic stage. To rule out the possibility that the lack of CR5-GFPþ
expression might be caused by the failure of electroporation, a
control construct CAG-DsRed was co-electroporated with CR5-GFP
construct. Strong CAG-DsRedþ cells (red) were observed in all
transfected brain tissues (Fig. 1D), conﬁrming that CR5 activity was
not detected in the embryonic stage.
CR5 activity is preferentially in the Sox5þ /NG2þ progenitors of the
neonatal forebrain
We next determined the cellular identity of transfection-
derived CR5-GFPþ cells by immunostaining with neural stem/
progenitor markers of Sox5 (Fig. 2A and F), NG2 (Fig. 2B and G),
Olig2 (Fig. 2C and H), BLBP (Fig. 2D and I), Mash1 (Fig. 2E and J),
GFAP (Fig. S3 A and B); astrocyte marker S100β (Fig. S3 C and D),
and neuronal marker NeuN (Fig. S3 E and F). Compared with the
control CAG-GFPþ cells, a signiﬁcantly higher percentage of
CR5-GFPþ cells were co-labeled with Sox5 (52.6% vs 23.1%) and
NG2 (68.9% vs 27.3%) (Fig. 2K). We found no CR5-GFPþ cells
were co-labeled with NeuN (Fig. S3E and F and Fig. 2K),
indicating that CR5 activity is not in the differentiated neurons.
The fact that the majority of the CR5-GFPþ cells were co-labeled
with Sox5 and NG2 indicates that CR5 was preferentially active
in Sox5þ/NG2þ progenitors during neonatal forebrain devel-
opment. To our surprise, only 37.8% of CR5-GFPþ cells were co-
labeled with Olig2 (Fig. 2C, H and K), suggesting that CR5 may
not be a cis-element/enhancer for Olig2 expression (Fig. 2C and
H and Table S1).
CR5 activity is exclusively in a subset of Sox5þ cells in the neonatal
ventral forebrain
The electroporation targets only a limited regional cell popula-
tion and results in a transient episomal gene expression. To
determine the spatiotemporal gene regulatory activity of CR5,
we thus generated transgenic mice containing the CR5-GFP con-
struct. The transgene CR5-GFP expression was examined at various
embryonic (E11.5, E13.5, E15.5, E17.5, E19.5) and postnatal stages
(P0, P7, P14, and P21). Consistent with results obtained from the
in vivo/utero electroporation, CR5-GFPþ cells in transgenic mice
were detected at a neonatal stage, E19.5 (n¼2) / P0 (n¼9); and
interestingly, they were predominately located in the ventral
forebrain (Fig. 3A). Even with extensive examinations, no GFP
expression was detected at embryonic stages and other postnatal
stages we examined (data not shown). Thus, CR5 activity is
exclusively in the neonatal ventral forebrain.
We then determined the cellular identities of transgenic
CR5-GFPþ cells by immunostaining the sagittal sections of P0
samples. We found that the vast majority of CR5-GFPþ cells
were co-labeled with Sox5 (82.6%, n¼3; po0.01) (Fig. 3B and
G). Although some CR5-GFPþ cells also co-labeled with other
progenitor markers, the percentages of co-labeled cells were
relatively low, e.g., NG2 (19.8%, n¼3, Fig. 3B and C), Gsx1 (28.7%,
n¼3, Fig. 3B and F), and mitotic cell marker PH3 (37%, n¼3,
Fig. 3B and G). Thus, CR5 activity is predominantly in the
Sox5þ cells.
Sox5 is known to be expressed in neural progenitors and
controls neocortical neuron differentiation (Azim et al., 2009;
Greig et al., 2013; Perez-Alcala et al., 2004). However, its role in
the ventral forebrain development is not clear. We then deter-
mined the pattern of Sox5 expression by immunohistochemistry.
A peak Sox5 expression was detected in both the dorsal and
ventral forebrain at P0 (Fig. 4A–C). Sox5 expression was not
detected at E17.5 (Fig. 4D and E) and dramatically reduced by P7
(Fig. 4D and F) in the ventral forebrain. This ventral forebrain
expression pattern of Sox5 is well correlated with CR5 activity in
this brain region.
Similar to electroporation results, a small percentage of CR5-
GFPþ cells were co-labeled with oligodendrocyte-lineage markers
Olig2 (2%) and PDGFRα (1.5%), astrocyte marker S100β (3.2%),
radial glia markers GFAP (4.5%) and BLBP (1.6%), intermediate
progenitor markers Tbr1 (2.2%), Tbr2 (3.6%), and Pax6 (3.3%) (Fig. 3
and Fig. S4). These results suggest that CR5 activity is time-
speciﬁc, brain region-restricted and is highly induced in a subset
of Sox5þ progenitor cells in the ventral forebrain.
Speciﬁc nuclear factors bind to CR5
Activation of CR5 requires the binding of transcription factor(s).
To determine which speciﬁc nuclear factors may bind to CR5, we
performed the electrophoretic mobility shift assays (EMSA). A total
of 7 probes were designed to span the whole length of CR5
(Table 2). EMSA results showed that two sub-regions within CR5
corresponding to probe #1 (Fig. 5A and B) and probe #2 (Fig. 5C
and D) have speciﬁc nuclear protein-binding activity. We analyzed
the transcription factor binding sites within these two sub-regions
using MatInspector (Genomatix, Germany) (Cartharius et al., 2005;
Quandt et al., 1995) to identify candidate binding sites for the
transcription factors (the last column in Table 2). After further
literature search, we narrowed down the number of candidate
transcription factor binding sites to Sox5, Phox2a and Phox2b. To
determine whether these three factors bind with CR5 in vivo, we
performed the chromatin immunoprecipitation (ChIP) assays
using chromatin obtained from brain tissues at various develop-
mental stages (P0, P7, P14, P21 and adult) and immunoprecipitated
using antibodies against the three protein factors individually.
Results from ChIP assays showed that Sox5 and Phox2a (but not
Phox2b) bound with CR5 (Fig. 5E), suggesting that binding of Sox5
and Phox2a is important for the activation of CR5 and its gene
regulatory activity.
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Lack of Sox5 binding site in CR5 alters gene regulatory activity
Since the majority of CR5-GFPþ were co-labeled with Sox5
(Fig. 3B and G) and Sox5 is known to control cell cycle progression
in neural progenitors and production of distinct neuronal cell
types (Martinez-Morales et al., 2010; Perez-Alcala et al., 2004), we
thus focused our further investigation on the role of Sox5 in CR5
activation. We next determined whether the Sox5 binding site is
required for gene regulatory activity using site-directed mutagen-
esis assay. Mutant CR5ΔSox5-GFP construct (deletion of AT from
CAAT) (Fig. 6A and B) was injected into the P0 mouse brain (for all
data points, nZ3) followed by electroporation to transfect the
neural progenitors in the SVZ. To our surprise, GFPþ cells were
observed from the mutant construct CR5ΔSox5-GFP, comparable to
the wild-type CR5-GFPþ cells (Fig. 6A') with no obvious difference
(Fig. 6B'), suggesting that Sox5 binding site is not essential for CR5
activation. However, after further analysis of the molecular iden-
tities of the resulting GFPþ cells, we found that CR5ΔSox5-GFPþ
cells and CR5-GFPþ cells have a different distribution (Fig. 6G and
Table S2). Compared with the CR5-GFPþ cell population, a
signiﬁcant lower percentage of CR5ΔSox5-GFPþ cells were co-
localized with Sox5 (52.6% vs 16.98%; Fig. 6C), NG2 (68.9% vs
23.98%; Fig. 6D) and Olig2 (36.6% vs 19.98%; Fig. 6E); while a
higher percentage of CR5ΔSox5-GFPþ cells were co-labeled with
BLBP (35.2% vs 58.58%; Fig. 6F). These ﬁndings suggest that
although Sox5 binding site is not required for the activation of
CR5, it affects the cellular speciﬁcity of CR5 in its gene regulatory
activity.
Discussion
The molecular mechanism underlying lineage-speciﬁc gene
expression is a key to the understanding of how cell diversity is
generated during the development of the CNS. In this study, we
report the identiﬁcation of a novel cis-element, CR5, an evolutio-
narily conserved non-coding DNA fragment located upstream of
Olig2 locus, capable of regulating gene expression especially in a
subpopulation of Sox5þ progenitor cells in the ventral forebrain
during neonatal development. We demonstrated that Sox5 bind-
ing site in CR5 is important for cell-speciﬁc gene regulatory
activity.
The VZ/SVZ progenitors in the embryonic and postnatal mam-
malian forebrain are known to generate olfactory interneurons,
Fig. 2. CR5 activity is preferentially in the Sox5þand NG2þ progenitors. Sagittal sections of the P7 mouse forebrain were immunostained with anti-GFP (green) antibody
and speciﬁc cell markers (red). GFPþ cells observed in the SVZ, corpus callosum, and neocortical areas after in vivo electroporation at P0 were further examined for the
expression pattern of progenitor markers including Sox5 (A and F), NG2 (B and G); Olig2 (C and H); radial glia marker BLBP (D and I); and type C cell marker Mash1 (E and J).
Boxed areas were shown in green and red channel separately. Double-labeled cells were indicated by arrowheads. Cells only express GFP but not labeled with a cell marker
were indicated by arrows. (K) A histograph showing the percentage of double labeled cells (GFPþ/cell markerþ) over GFPþ cells. Error bars indicate values of the standard
deviation. The histograph also includes data of immunostaining with astrocyte markers GFAP, S100ß, and neuronal marker NeuN (see Fig. S3). Compare with the control
group, a higher percentage of the CR5-GFPþ cells were co-stained with Sox5, NG2. No signiﬁcant difference was observed with the S100β, GFAP, BLBP, and Mash1 co-
labeling. The signiﬁcance of difference between CR5 and the control group was assessed by student's t-test (see Table S1). (**po0.01; n¼3). Cx, cortex; cc, corpus callosum;
LV, lateral ventricle. Scale bar¼20 mm.
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astrocytes, and oligodendrocytes (Marshall et al., 2005; Marshall
et al., 2003; Menn et al., 2006). The SVZ population also contains
radial glia that serves as neural progenitors (Middeldorp et al.,
2010). Consistent with previous observations, our electroporation
experiments showed that CAG driven reporter GFP or DsRed
expression was detected in all above mentioned cell types in both
embryonic and neonatal stages, while CR5 driven GFP expression
was only detected in the SVZ at a stage between P0 to P7, but not
in the embryonic stages (Figs. 1 and 2 and Fig. S3). Together with
data from the transgenic mice (Fig. 3), we demonstrated that CR5
activity exists only in the neonatal developing brain.
In both the in vivo electroporation and transgenic mouse
studies, the majority of CR5-GFPþ cells were co-localized with
Sox5 (82.6% in transgenic animals and 52.6% in electroporation
experiments) indicating that CR5 activity is preferentially in a
subpopulation of Sox5þ progenitors. The difference in the per-
centage of CR5-GFPþ/Sox5þ cells observed in the two experi-
ments may be due to the fact that CR5-GFP construct targets only
the SVZ progenitors at P0 in the electroporation experiment and
resulted in a transient episomal GFP expression; while in trans-
genic animals, CR5-GFP construct targets the embryonic stem
cells, CR5-GFP was integrated into the genome, and resulted in a
spatiotemporal regulated GFP expression. We noticed that there
was also a large difference in the percentages of CR5-GFPþ/NG2þ
cells, i.e., 19.8% in transgenic animals and 68.9% in electroporation
experiments. This can be explained again by the difference of the
two methods targeting different cell population, i.e., embryonic
neural stem cells in transgenic mouse study vs SVZ progenitors at
neonatal stage (P0) in electroporation experiments.
It is interesting that CR5-GFPþ cells were not detected in the
postnatal SVZ of the transgenic animals (Figs. 1–3), indicating that
CR5 activity may not be in the SVZ region of the cerebral cortex.
Alternatively, it is also possible that the CR5-GFP level was too low
to be detected. Although, CR5 activity may not be in the cerebral
cortex, the electroporation derived GFPþ cells may be a result of
the electrical stimulation to the SVZ progenitors. The transgenic
experiments reveal the spatiotemporal activity of CR5 during CNS
development, while the in vivo electroporation experiments pro-
vide a rapid screen method for functional cis-elements. Our results
from the CR5-GFP transgenic mouse study provide not only
evidence to support the conclusion that CR5 activity is in a
subpopulation of Sox5þ progenitors but also further determined
that this progenitor population is located in the neonatal ventral
forebrain (Figs. 3 and 4). Thus, CR5 activity is in a spatiotemporally
restricted manner.
Sox5 is well known for its function in controlling cell cycle and
sequential generation of distinct corticofugal neuron subtypes. Our
analysis revealed a novel role of Sox5 in neural progenitors of the
neonatal ventral forebrain regulated by CR5 activity (Fig. 3). To
support this, a transient Sox5 expression was detected in the P0
ventral forebrain (Fig. 4). By P7, Sox5 expression was dramatically
decreased and barely detectable (Fig. 4). The observation that no
CR5-GFPþ cells were detected in the transgenic neocortex where
Sox5 is highly expressed implies that CR5 was not active in this
brain region. Thus, Sox5 expression in different brain areas may be
regulated by different mechanisms.
Despite its location upstream of the Olig2 gene, CR5 may not
directly regulate Olig2 expression as the majority of CR5-GFPþ
Fig. 3. CR5 is preferentially active in Sox5 expressing cells of the ventral forebrain around postnatal day 0. (A) Sagittal and coronal brain sections of P0 transgenic mouse
show that CR5-GFPþ cells were primarily located in ventral forebrain. Diagrams of the sagittal and coronal planes show the distribution pattern of CR5-GFPþ cells indicated
by green dots. Immunostaining results with anti-GFP antibody of the boxed area were displayed on the right images. CR5-GFPþ cells in the ventral forebrain from sagittal
samples were immunostained with speciﬁc cell marker Sox5 (C), NG2 (D), Pax6 (E), Gsx1 (F), and PH3 (G). A histograph showing the percentage of double labeled cells
(GFPþ/cell markerþ) over GFPþ cells (B), including other markers, e.g., neuronal marker Tbr1 and Tbr2; oligodendrocyte marker Olig2 and PDGFRα, radial glia marker GFAP
and BLBP; and astrocyte marker S100β (Fig. S4). Error bars indicate values of the standard deviation (see Table S2). Scale bar¼50 mm.
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cells were not co-localized with Olig2 or oligodendrocyte progeni-
tor marker PDGFRα (Figs. 2-3 and Fig. S3). Thus, CR5 activity may
not be in the oligodendrocyte lineage. Since CR5-GFPþ cells were
co-localized with Sox5 and not with Olig2, thus, Sox5 may not
directly regulate Olig2 expression. This is consistent with the role
of Sox5 in suppressing myelin gene expression in oligodendrocytes
(Stolt et al., 2006). Sox5 expression is found in VZ cells, astroglia,
and speciﬁc neuronal populations (Batista-Brito et al., 2009; Lai
et al., 2008) and not in differentiating oligodendrocytes (Stolt
et al., 2006).
The diversity of neuronal progeny in the early postnatal brain
contributes to the anatomical organization and cell speciﬁcation
(Lledo et al., 2008). Recent studies have revealed that distinct
molecules mobilize stem cells toward neurogenesis in different
regions (Lopez-Juarez et al., 2013). Many molecules exerts regula-
tory function in a region-speciﬁc manner (Brill et al., 2008; Lledo
et al., 2008; Lopez-Juarez et al., 2013; Merkle et al., 2007). Given
the regionally restricted expression of CR5-GFP, our results suggest
that CR5 is an important regulatory element for proper lineage
progression of Sox5þ/NG2þ subpopulation. Previous studies
demonstrated that Olig2 is not co-expressed with NG2 in the
ventral forebrain; NG2þ/Olig2- cells in this area differentiated
into astrocytes, but not oligodendrocytes (Zhu et al., 2012). A
subpopulation of CR5-GFPþ/NG2þ in the transgenic ventral brain
indicates that CR5 might play a role in controlling cell diversity in
this brain region. In addition, a recent study suggests that Gsx1 is
likely to be a regulator in the development of lateral and ventral
neural stem cells (Lopez-Juarez et al., 2013). Our ﬁnding that a
subpopulation of CR5-GFPþ cells in transgenic animals were co-
localized with Gsx1 (Fig. 3F) further supports the notion that CR5
is involved in the generation of cell diversity in the forebrain.
Gene regulatory ability of CR5 is attributed to the binding
activities with speciﬁc protein factors. We identiﬁed Sox5 as a CR5
binding trans-acting factor, which was conﬁrmed by EMSA, ChIP
(Fig. 5), and site-directed mutagenesis and in vivo electroporation
assays (Fig. 6). Although no obvious changes in the level of GFP
expression was detected with CR5ΔSox5-GFP construct, the mutant
Sox5 binding site did alter the composition of reporter gene
Fig. 4. Sox5 expression is in the neonatal ventral forebrain. Sagittal sections from mouse brain at P0 (A–C), E17.5 (D and E), and P7 (D and F) were immunostained with anti-
Sox5 antibody. Strong Sox5 expression was detected in both the ventral forebrain (B) and dorsal cortex (C) at P0, but not detected in the E17.5 ventral forebrain (E). Weak
Sox5 expression was detected in the P7 ventral forebrain (F). Diagram of sagittal brain are shown in A and D. Dashed boxed area in the diagram are shown in the right images
with corresponding labels. Sox5 expression pattern at P0 brain is indicated by red dots while CR5-GFP expression is indicated by green dots. VB, ventral forebrain; CX: cortex.
Scale bar¼50 mm.
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expression in the resulting GFPþ cell population: a dramatic
decrease of the percentage of CR5ΔSox5-GFPþ cells co-labeled
with Sox5 and NG2, and a signiﬁcant increase in the percentage
of CR5ΔSox5-GFPþ cells co-labeled with BLBP (Fig. 6). These
ﬁndings suggest that although Sox5 binding site is not required
for the activation of CR5, it does affect the speciﬁcity of CR5 in
Sox5 cell population.
Sox5 belongs to SoxD group, which contains two other factors
Sox6 and Sox13 (Guth and Wegner, 2008). Our analysis showed
that CR5 contains binding sites for Sox5, but not for Sox6 or Sox13.
Fig. 5. CR5 interacts with speciﬁc nuclear protein factors. Analysis of homologous CR5 sequences from 8 species by a web based sequence analysis tool Weblogo revealed
two highly conserved motifs (A and C). Electrophoretic mobility shift assays (EMSA) were performed to identify the in vitro binding activity of nuclear proteins with CR5.
Among a total number of seven probes that cover the entire CR5, probe #1 (A and B) and probe #2 (C and D) showed binding activity. The competition assay was carried out
using unlabeled probes at 40-fold higher concentration. The nuclear extracts from developing mouse brain at various stages were obtained (P0: lanes 2 and 3; P7: lanes 4 and
5; Adult: lanes 6 and 7). For probe #1, the arrowheads indicate the retarded band obtained using the P0 brain nuclear extracts (lane 2). The shift disappeared when
competitor was added (lane 3). No shift was observed in the assays using P7 and adult mouse brain nuclear extracts (lanes 4–7). For Probe #2, the retarded bands were
observed for all the stages (arrowhead, lane 2, 4, 6). The shift diminished when competitor was added (arrowhead, lane 3, 5, 7). Chromatin immunoprecipitation (ChIP)
assays detected in vivo binding of protein factors (Phox2a, Phox2b, and Sox5) to CR5 (E). Chromatin obtained from P0, P7, P14, and P21 brain tissues of mouse pups was
immunoprecipitated using antibodies against individual protein factor. The pure mouse IgG antibody was used as a negative control. The input represented 1% of the total
chromatin extract. The precipitated DNA fragments were ampliﬁed by a set of primers ﬂanking CR5 sequences. The PCR products of the expected size of 416 bp were
obtained. As a negative control, primers ﬂanking a random sequence of 700 bp which does not include speciﬁc binding sites were tested and no PCR product was detected.
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For this reason, the role of Sox6 or Sox13 in regulating CR5 activity
was not examined. However, the possibility that Sox6 and/or
Sox13 may interact with Sox5 and participate in CR5 activation
cannot be ruled out.
A major challenge in understanding how various cell types in
the CNS are generated is to elucidate the mechanism of cell-
speciﬁc gene expression. The identiﬁcation of the novel gene
regulatory element in this study represents one step in this effort.
Based on our ﬁndings, we propose that the cis-element CR5 and its
binding factors participate in the regulation of cell-speciﬁc gene
expression in a spatiotemporal manner. Our study provides an
example of such cell-speciﬁc gene expression mediated by a direct
interaction of trans-acting factors (e.g., Sox5 and possibly Phox2a)
with a cis-element (e.g., CR5). This study also represents a useful
and effective method for the functional study of non-coding
regulatory sequences and their binding protein factors in cell
lineage development.
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